<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20241119063772N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-08</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of occupation-based bilateral training in children with unilateral spastic cerebral palsy</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of occupation-based bilateral training on participation in Activities of Daily Livings (ADLs) in 6-12 years old children with unilateral spastic cerebral palsy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-05-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/80453</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The participants will be recruited from the clients referred to occupational therapy clinics in Tehran based on the inclusion criteria and will be allocated to the control and intervention groups using a random number table. Accordingly, one of the researchers who is not involved in the intervention process will determine the placement of the participants in one of the two control and intervention groups based on the random number table. Participants and the outcome assessor will be blind about group allocation, Blinding description: In this single-blind study, the outcome assessor will be blind to the allocation of participants to groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Children with unilateral cerebral palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, which consists of 15 children, children with unilateral cerebral palsy receive bilateral upper and lower limb exercises, the precise protocol of which was designed by a panel of experts. The intervention is provided over 14 days both in the clinic setting and remotely (online). The number of hours of intervention in face-to-face sessions ranges from 3 to 5 hours, depending on the conditions (the child's attention level, etc.). Intervention 2: Control group: In this group, children with unilateral spastic hemiplegic cerebral palsy will receive routine occupational therapy to treat this condition.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Pashmdar Fard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti University of Medical Sciences, Faculty of Rehabilitation Sciences, opposite Bu Ali Hospital, Damavand Street, Imam Hossein (AS) Square, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7756 1721</telephone>
        <email>m.pashmdarfard@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahnaz Hejazi Shirmard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti University of Medical Sciences, Faculty of Rehabilitation Sciences, opposite Bu Ali Hospital, Damavand Street, Imam Hossein (AS) Square, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7756 1721</telephone>
        <email>m.hejazishirmard@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The child has received a diagnosis of spastic unilateral hemiplegia cerebral palsy.
The child is between 6 and 12 years old.
The child is at levels II, III, and IV of the GMFCS scale.
The child is at levels II and III of the MACS scale.
The child has the ability to grasp light objects and raise the more affected hand more than 15 cm above the table surface.
The child has not received upper and lower limb surgery and Botox injections in the past 6 to 12 months and does not intend to do so during the implementation of the interventions.
The child's intelligence score is above 70</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The family or the child is unwilling to continue the interventions.
The child has uncontrolled seizures.
The child has visual or cognitive problems.
The child is unable to actively participate in the assessment process.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spastic hemiplegic cerebral palsy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, which consists of 15 children, children with unilateral cerebral palsy receive bilateral upper and lower limb exercises, the precise protocol of which was designed by a panel of experts. The intervention is provided over 14 days both in the clinic setting and remotely (online). The number of hours of intervention in face-to-face sessions ranges from 3 to 5 hours, depending on the conditions (the child's attention level, etc.).</i_keyword>
      <i_keyword>Control group: In this group, children with unilateral spastic hemiplegic cerebral palsy will receive routine occupational therapy to treat this condition.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The level of children's participation in daily life activities. Timepoint: All study variables will be assessed before the start, after the intervention (day 14), and one month after the intervention (follow-up assessment). Method of measurement: Canadian occupational performance measure.</prim_outcome>
      <prim_outcome>Assessing the ability level of children's balance and lower extremities. Timepoint: All study variables will be assessed before the start, after the intervention (day 14), and one month after the intervention (follow-up assessment). Method of measurement: Pediatric balance scale.</prim_outcome>
      <prim_outcome>Assessing children's manual skills. Timepoint: All study variables will be assessed before the start, after the intervention (day 14), and one month after the intervention (follow-up assessment). Method of measurement: Children's Hand-use Experience Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Assessment of gross motor skills. Timepoint: All study variables will be assessed before the start, after the intervention (day 14), and one month after the intervention (follow-up assessment). Method of measurement: The Gross Motor Function Measure.</sec_outcome>
      <sec_outcome>Assessing the level of upper extremities ability and manual dexterity. Timepoint: All study variables will be assessed before the start, after the intervention (day 14), and one month after the intervention (follow-up assessment). Method of measurement: Box and Block Test.</sec_outcome>
      <sec_outcome>Investigating the level of children's participation in daily life activities. Timepoint: All study variables will be assessed before the start, after the intervention (day 14), and one month after the intervention (follow-up assessment). Method of measurement: Pediatric Evaluation of Disability Inventory.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-11-10</approval_date>
        <contact_name>Research Ethics Committee of Shahid Beheshti University of Medical Sciences Vice President of Resear</contact_name>
        <contact_address>Shahid Beheshti University of Medical Sciences, School of Rehabilitation, opposite Bu Ali Hospital, Damavand Street (New Tehran), Imam Hossein (AS) Square, Tehran tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
